Anavex Life Sciences Corp (AVXL)

[Hosai]

Which PR did they say that in?
To me I think the EMA at the very least go with a conditional approval. These are the general guideliens for phase 4 studies:

There's substantial evidence of the drug's efficacy and safety, but more data is needed to confirm or expand on these findings.
The drug addresses a serious or life-threatening condition where available treatments are limited.
The potential benefits of immediate access to the drug outweigh the risks of unknown long-term effects.